LCTC

Lifeloc Technologies earns a Neutral rating with a 45.3 composite score and 2/5 conviction. Fundamentals provide the strongest contribution at 53, supported by relatively favorable gross-margin and operating-margin subscores despite absolute losses and a stretched financial condition. Regulatory ranks second at 49, with a strong enforcement subscore offset by weak filing cadence. Market contributes 40 because institutional pricing feeds show no available quote, limiting price discovery and confirmation of investor demand. Editorial contributes 30, reflecting no newsroom or brief activity in CIN newsroom coverage. The resulting pillar mix places LCTC firmly in the Neutral band: operating execution offers measurable support, but limited visibility, a small capitalization profile, and absent market confirmation constrain conviction.

Licensed fundamentals data show year-over-year revenue growth of roughly 0.7%, indicating stability rather than meaningful expansion. Gross margin stands near 41.1%, a respectable level that drives the 68.6 gross-margin subscore, while the negative 5.6% operating margin still produces the highest fundamentals subscore at 72.6. That relative score does not override the loss profile: net income is approximately negative $2.33 million and EBITDA is approximately negative $0.67 million. The market capitalization is about $9.55 million, generating no support from the capitalization-tier subscore, while the cash-burn ratio is approximately 7.0% and the cash-runway subscore is 62.3. The stretched financial condition therefore remains central. Primary regulatory filings show no dated latest filing, producing a cadence subscore of 25, although zero regulatory events over both 90 and 180 days and zero enforcement hits support the 80 enforcement subscore.

The forward catalyst rests squarely on fundamentals, the highest-scoring pillar. A future primary regulatory filing that demonstrates faster revenue growth, preserves the roughly 41% gross margin, and narrows the operating and EBITDA losses would strengthen the investment case without relying on regulatory or editorial momentum. Improved filing cadence would also make that operating progress easier to validate, but the rating’s upside path remains earnings-driven. The single most important signal to watch is sustained improvement in operating margin alongside positive revenue growth.